Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, G1 Therapeutics (GTHX) has a market cap of $0.38 billion USD. According to our data, G1 Therapeutics is ranked No.6262 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Sep 18, 2024 | $0.38 B |
134.43%
|
| Dec 29, 2023 | $0.16 B |
-43.83%
|
| Dec 30, 2022 | $0.29 B |
-46.82%
|
| Dec 31, 2021 | $0.54 B |
-43.25%
|
| Dec 31, 2020 | $0.95 B |
-31.93%
|
| Dec 31, 2019 | $1.39 B |
38.02%
|
| Dec 31, 2018 | $1.01 B |
-3.48%
|
| Dec 29, 2017 | $1.05 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
| Market Cap | = | GTHX Stock Price | * | GTHX Shares Outstanding |
| = | $7.15 | * | 52.76 M | |
| = | $0.38 B |